Related Experiment Videos
Frequent clonal chromosomal changes in human non-malignant tumors
1Histology-Embryology-Cytogenetics Laboratory, Faculty of Medicine, INSERM U314, University of Reims, France.
International Journal of Cancer
|November 15, 1989
Summary
Chromosomal abnormalities are present in non-malignant human tumors. These genetic changes, particularly involving chromosome 7, may drive tumor development and progression.
Area of Science:
- Cytogenetics
- Oncology
- Human Pathology
Background:
- Non-malignant human solid tumors can exhibit chromosomal alterations.
- Understanding these changes is crucial for identifying early tumorigenesis events.
Purpose of the Study:
- To investigate the cytogenetic profile of non-malignant human solid tumors.
- To identify common chromosomal aberrations and their potential role in tumor development.
Main Methods:
- Performed cytogenetic analysis on 109 non-malignant human solid tumors.
- Analyzed tumors from various histological types including epithelial, mesenchymal, embryonal, and neurogenic tissues.
- Examined chromosome counts and karyotypic alterations (numerical and structural).
Main Results:
- Most tumors had diploid chromosome counts.
- Clonal chromosomal changes were detected in 37% of tumors.
- Numerical deviations (20%), structural rearrangements (12%), and both (5%) were observed.
- Chromosome 7 was the most frequently altered, involved in 25% of abnormal specimens.
Conclusions:
- Chromosomal changes contribute to non-malignant tumorigenesis.
- Cytogenetic analysis of these tumors offers insights into genetic events driving benign to malignant transitions.
- Further research into these genetic alterations may reveal new therapeutic targets.